Home/Filings/8-K/0001428336-26-000003
8-K//Current report

HEALTHEQUITY, INC. 8-K

Accession 0001428336-26-000003

$HQYCIK 0001428336operating

Filed

Jan 11, 7:00 PM ET

Accepted

Jan 12, 9:01 AM ET

Size

174.4 KB

Accession

0001428336-26-000003

Research Summary

AI-generated summary of this filing

Updated

HealthEquity, Inc. Announces FY2027 Outlook; Reaffirms FY2026 Guidance

What Happened
HealthEquity, Inc. (HQY) filed an 8-K on January 12, 2026 (Item 7.01) to furnish a press release that announces the company's initial outlook for its fiscal year ending January 31, 2027 and reaffirms previously provided guidance for the fiscal year ending January 31, 2026. Management will discuss these estimates at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026 at 3:00 PM Pacific Time. The company said an audio webcast and presentation materials will be available on its investor site (ir.healthequity.com). The filing was signed by James Lucania, Executive VP and CFO.

Key Details

  • Press release furnished as Exhibit 99.1 to the Form 8-K, dated January 12, 2026.
  • Announced initial outlook for fiscal year ending January 31, 2027; reaffirmed guidance for fiscal year ending January 31, 2026.
  • Management presentation scheduled for Jan 13, 2026 at 3:00 PM PT at the 44th Annual J.P. Morgan Healthcare Conference; audio webcast and slides to be available on ir.healthequity.com.
  • The press release information is furnished (not “filed”) under Regulation FD and therefore is not subject to Section 18 liability or automatically incorporated by reference in other SEC filings.

Why It Matters
For investors, the filing signals HealthEquity is providing forward-looking expectations for FY2027 while confirming the company’s prior FY2026 guidance, which can affect earnings and revenue modeling and near-term investor confidence. The JP Morgan presentation offers an opportunity for management to elaborate on assumptions behind the outlook. Note the disclosure status (“furnished, not filed”)—the company is sharing the information broadly under Regulation FD but limits its formal incorporation into other SEC filings.